Abstract
Systemic bacterial and fungal infections have increased in recent years as a result of an increase in the amount of disabling disorders that affect the immune system, such as AIDS, blood cancers, overdose, corticosteroid medications, and broad-spectrum antibiotics. Acute and subsequent candida infections with drug-resistance features, such as fluconazole, are common. Because of the frequency and spread of fungal and bacterial illnesses, the search for remedies is more intense than ever. Because of their unique biocompatibility and bioavailability, plant chemicals are beneficial in the treatment of fungal and bacterial infections. The market for new antifungal and antibacterial drugs remains tiny, although resistance to many antibiotics is growing, particularly in patients receiving long-term treatment. Given the vast antibacterial potentials of natural chemicals derived from plants and endophytes, as an alternate source remains poorly unexplored. Endophytes and medicinal plant species have primary and secondary compounds that can hinder or inactivate infections. Many researches on the antibacterial and antifungal properties of these metabolites have recently been published.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: international journal of engineering technology and management sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
